Skip to Main Content
+
Falzon  D  et al. World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update. Eur Respir J 49:1602308, 2017.
+
Getahun  H  et al. Latent Mycobacterium tuberculosis infection. N Engl J Med 372:2127, 2015.
+
Nahid  P  et al. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America clinical practice guidelines: Treatment of drug-susceptible tuberculosis. Clin Infect Dis 63:853, 2016.
+
Pai  M  et al. Tuberculosis. Nat Rev Dis Primers 2:16076, 2016.
+
Tameris  MD  et al. Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: A randomized, placebo-controlled phase 2b trial. Lancet 381:1021, 2013.
+
Uplekar  M  et al. WHO’s new end TB strategy. Lancet 385:1799, 2015.

WEBSITES

+
World Health Organization: Guidance for national tuberculosis programmes on the management of tuberculosis in children. 2nd ed. Geneva, WHO, 2014.Available fromhttp://www.who.int/tb/publications/childtb_guidelines/en/. Accessed December 12, 2017.  [PubMed: ] [[XSLOpenURL/]]
+
World Health Organization: Global tuberculosis report 2017. Geneva, WHO, 2017.Available fromhttp://www.who.int/tb/publications/global_report/en/. Accessed December 12, 2017.
+
World Health Organization: Treatment of tuberculosis. Guidelines for treatment of drug-susceptible tuberculosis and patient care.2017 update. Geneva, WHO, 2017.Available fromhttp://apps.who.int/iris/bitstream/10665/255052/1/9789241550000-eng.pdf?ua=1. Accessed December 12, 2017.

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.